Adeoye Y. olukotun, M.D., MPH, FACC

Dr. Olukotun has served as a director since August 2006. Dr. Olukotun has served as chief medical officer of VIA Pharmaceuticals, Inc., a biotechnology company, since September 2004. Dr. Olukotun founded CR Strategies, LLC, a clinical research and development consulting firm, and served as its chief executive officer from March 2000 to December 2003. Dr. Olukotun also was chief medical officer of Esperion Therapeutics, Inc., a cardiovascular drug development company, from July 2001 to April 2004. Dr. Olukotun was Vice President of Medical and Regulatory Affairs and Chief Medical Officer at Mallinckrodt, Inc., a healthcare company, from June 1996 to January 2001. Prior to joining Mallinckrodt, Dr. Olukotun was employed at Bristol-Myers Squibb Company, most recently serving as Vice President. Dr. Olukotun serves on the board of directors of BioMedical Systems Corporation, a private biotechnology company, and D&R Greenway Land Trust, a non-profit organization. Dr. Olukotun received his M.D. from Albert Einstein College of Medicine and a MPH degree from Harvard University School of Public Health.